The cumulative incidence of atrial fibrillation in the hospitalized medical patient: A systematic review and Meta-analysis
Clicks: 2
ID: 314631
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #24 of 38 articles by views in European Heart Journal Open
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Introduction New-onset atrial fibrillation (NOAF) is the most common cardiac arrhythmia occurring in hospitalised patients. NOAF confers a significant risk of cardiovascular morbidity and mortality in the form of symptomatic tachyarrhythmia, heart failure, stroke and sudden cardiac death. It is unclear what the cumulative incidence of NOAF is in the hospitalised medical (non-surgical) patient. Methods MEDLINE and Embase were searched for studies published between 01/01/2000 and 10/03/2026. All studies reporting the cumulative incidence of NOAF in hospitalised medical (non-surgical) patients were included. The pooled cumulative incidence of NOAF, 95% confidence intervals (CI), and 95% prediction intervals (PI) were computed using a random-effects model. The inconsistency index (I2) was calculated to measure heterogeneity. Subgroup analyses were also performed. A study protocol was registered with the PROSPERO database of systematic reviews (CRD42024626333). Results A total of 10,323 articles were identified from our searches, and of these 62 met the inclusion criteria. The cumulative incidence of NOAF across all studies was 99,474 (crude incidence 2.4%) out of 3,608,663 patients. The pooled cumulative incidence of NOAF was 9% (95% CI 7–11%), with substantial heterogeneity (I2 = 99.9%) and a wide prediction interval (1–42%). In meta-regression, ICU setting (OR 2.46, 95% CI 1.22–5.00; p = 0.013) and prospective study design (OR 1.73, 95% CI 1.01–2.95; p = 0.044) were independently associated with higher NOAF incidence, while year of publication and use of administrative data were not significant. Subgroup analyses demonstrated consistently higher incidence in prospective and critically ill populations. Conclusion The cumulative incidence of NOAF in patients hospitalised for acute medical illness varies significantly dependent on disease severity and methods to detect it. Attempts to pool data across studies are limited by differences in study design, patient populations and disease severity.
| Reference Key |
openalex_W7162124416
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hani Essa, Ashwin Balu, Gregory Y H Lip, Ingeborg Welters |
| Journal | European Heart Journal Open |
| Year | 2026 |
| DOI |
10.1093/ehjopen/oeag080
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.